ID

14053

Descripción

This is an open-label (all people know the identity of the intervention), multicenter study in genotype 1 chronic HCV infected liver transplant patients who will be treated for 12 weeks with telaprevir 750 mg every 8 hours given in combination with Peg-IFN-alfa-2a and ribavirin followed by 36 weeks of treatment with Peg-IFN-alfa-2a and ribavirin alone. The total treatment duration will be 48 weeks. Safety will be evaluated throughout the study and will include evaluations of adverse events, clinical laboratory tests, electrocardiogram, vital signs, and physical examination. NCT01571583

Palabras clave

Versiones (1)
  1. 23/3/16 23/3/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

23 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

VX-950HPC3006 NCT01571583 Trial Termination

Inglés

VX-950HPC3006 NCT01571583 Trial Termination

1 formularios  
Trial Completion/Discontinuation
Descripción

Trial Completion/Discontinuation

trial completion/discontinuation
Descripción

please specify if the subject completed the entire course of the follow-up phase of the trial as specified in the protocol or if the subject discontinued the trial early if discontinued pelase specify the primary reason for early termination in the following items

Tipo de datos

integer

Alias
UMLS CUI [1]
C2732579
UMLS CUI [2]
C2718058
adverse event related event, please specify
Descripción

(including death, abnormal lab values, intercurrent illness and pregnancy)

Tipo de datos

text

Alias
UMLS CUI [1]
C0877248
Subject lost to follow-up. Date of last contact with subject (visit, call...) in this trial
Descripción

Date of last contact with subject

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0805839
UMLS CUI [1,2]
C0681850
Subject withdrew consent. Date consent withdrawn
Descripción

date consent withdrawn

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
sponsor's decision
Descripción

sponsor's decision

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2347796
UMLS CUI [1,2]
C0679006
other, please specify
Descripción

other reason

Tipo de datos

text

Alias
UMLS CUI [1]
C3840932
did the subject take all investigational medication within the expiry timeframe?
Descripción

investigational medication within expiry timeframe

Tipo de datos

integer

Alias
UMLS CUI [1]
C0013230
Is the subject rolling over to another Tibotec sponsored Trial?
Descripción

subject participation status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
Volver a la parte superior de la página

Similar models

VX-950HPC3006 NCT01571583 Trial Termination

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Trial Completion/Discontinuation
Item
trial completion/discontinuation
integer
C2732579 (UMLS CUI [1])
C2718058 (UMLS CUI [2])
trial completion/discontinuation
Code List
trial completion/discontinuation
CL Item
completed (1)
CL Item
discontinued (2)
adverse event
Item
adverse event related event, please specify
text
C0877248 (UMLS CUI [1])
Date of last contact with subject
Item
Subject lost to follow-up. Date of last contact with subject (visit, call...) in this trial
date
C0805839 (UMLS CUI [1,1])
C0681850 (UMLS CUI [1,2])
date consent withdrawn
Item
Subject withdrew consent. Date consent withdrawn
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
sponsor's decision
Item
sponsor's decision
boolean
C2347796 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])
other reason
Item
other, please specify
text
C3840932 (UMLS CUI [1])
Item
did the subject take all investigational medication within the expiry timeframe?
integer
C0013230 (UMLS CUI [1])
investigational medication within expiry timeframe
Code List
did the subject take all investigational medication within the expiry timeframe?
CL Item
yes (1)
CL Item
no (2)
CL Item
not applicable (3)
subject participation status
Item
Is the subject rolling over to another Tibotec sponsored Trial?
boolean
C2348568 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial